FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis
Ruimin Liu1, Yan Sun1, Shuai Chen1
1School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.
Abstract:
Our previous study demonstrated that GAB2 promoted tumorigenesis in liver tissue and was a potential target for the treatment of hepatocellular carcinoma (HCC). Here, we identified that the tumour suppressor protein Forkhead box D3 (Foxd3) is a transcriptional repressor of the Gab2 gene. In human HCC cells, FOXD3 expression is low, but GAB2 expression is abundant. Increased Foxd3 expression inhibited the expression of Gab2 in a dose-dependent manner. Ectopic expression of Foxd3 in HCC cells reduced Gab2-mediated promotion of cell proliferation and migration in vitro. Foxd3 also inhibited Gab2-stimulated phosphorylation of Jak2 and Stat3. Furthermore, the protein levels of Foxd3 and Gab2 had a clear negative correlation: Gab2 expression was induced, whereas Foxd3 expression was suppressed in most tumour tissues in mice with diethylnitrosamine (DEN)-induced hepatocellular carcinoma. These results suggest that the tumour suppressor Foxd3 and tumour enhancer Gab2 mutually inhibit each other to synergistically control the occurrence of HCC, providing a novel mechanism for treating this disease.
Insights
The tumor suppressor Forkhead box D3 (Foxd3) inhibits the growth-promoting gene GAB2 in liver cancer. This mutual inhibition offers a new therapeutic strategy for hepatocellular carcinoma (HCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- GAB2 was previously identified as a promoter of hepatocellular carcinoma (HCC) tumorigenesis.
- Understanding the regulatory mechanisms of GAB2 is crucial for developing targeted HCC therapies.
Purpose of the Study:
- To investigate the role of Forkhead box D3 (Foxd3) as a transcriptional regulator of the GAB2 gene in HCC.
- To elucidate the functional relationship between Foxd3 and GAB2 in HCC development.
Main Methods:
- Analysis of FOXD3 and GAB2 expression in human HCC cells.
- In vitro studies involving ectopic Foxd3 expression in HCC cells.
- Western blot analysis to assess protein phosphorylation (Jak2, Stat3).
- Examination of Foxd3 and Gab2 protein levels in a mouse model of diethylnitrosamine (DEN)-induced HCC.
Main Results:
- Foxd3 acts as a transcriptional repressor of the Gab2 gene.
- Low FOXD3 and high GAB2 expression were observed in human HCC cells.
- Increased Foxd3 expression inhibited Gab2 expression, cell proliferation, and migration in vitro.
- Foxd3 suppressed Gab2-stimulated Jak2 and Stat3 phosphorylation.
- A negative correlation between Foxd3 and Gab2 protein levels was observed in HCC tissues.
Conclusions:
- Foxd3 functions as a tumor suppressor by inhibiting GAB2 in HCC.
- The reciprocal inhibition between Foxd3 and Gab2 plays a synergistic role in HCC occurrence.
- Targeting this Foxd3-Gab2 axis presents a novel therapeutic avenue for hepatocellular carcinoma.
More Related Videos
Related Concept Videos
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Abnormal Proliferation
Cell Specific Gene Expression
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...


